Abn Amro Bank N.V. Dexcom Inc Transaction History

Abn Amro Bank N.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$59.83 - $87.57 $922,159 - $1.35 Million	-15,413 Closed	0 $0
Q3 2024 Aug 28, 2025	SELL	$64.0 - $116.06 $615,680 - $1.12 Million	-9,620 Closed	0 $0
Q2 2024 Aug 28, 2025	BUY	$110.31 - $140.45 $1.06 Million - $1.35 Million	9,620 New	9,620 $1.1 Billion
Q1 2024 Aug 28, 2025	SELL	$114.22 - $140.1 $1.3 Million - $1.59 Million	-11,366 Closed	0 $0
Q4 2023 Aug 28, 2025	BUY	$75.49 - $124.16 $858,019 - $1.41 Million	11,366 New	11,366 $1.42 Billion

Q3 2023 Aug 28, 2025	SELL	$86.06 - $137.93 $869,980 - $1.39 Million	-10,109 Reduced 39.61%	15,413 $1.44 Billion
Q2 2023 Aug 28, 2025	SELL	$112.47 - $130.98 $297,708 - $346,704	-2,647 Reduced 9.4%	25,522 $3.28 Billion
Q1 2023 Aug 28, 2025	BUY	$104.0 - $122.92 $2.93 Million - $3.46 Million	28,169 New	28,169 $3.28 Billion

1,091

445M

6.78M

7.25M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Abn Amro Bank N.V., based on Form 13F filings with the SEC.

Stay updated on Abn Amro Bank N.V. with notifications on news.